Journals / Ordu Üniversitesi Bilim ve Teknoloji Dergisi / 2021 / Cilt: 11 - Sayı: 1

Molecular Docking Analysis of Benzimidazolium Type Molecules with VEGFR-2 and TrxR Crystal Structures for Evaluating Anti-Cancer Activity

Benzimidazolyum Tipi Moleküllerin Anti-Kanser Aktivitesini Değerlendirmek İçin VEGFR-2 ve TrxR Kristal Yapılarıyla Moleküler Doking Analizi

Pages
36–44
Publication Date
2021-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, the interactions of optimized molecules with VEGFR-2 and TrxR crystal structures were analyzed by using molecular docking methods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:N-heterocyclic carbenes are a family of molecules that are frequently studied for their bioactivity.
📊
Key Findings & Data:In this study, previously characterized of 1-(allyl)-3-(2,4,6-trimethylbenzyl)benzimidazolium chloride (1) and 1-(allyl)-3-(2,3,4,5,6-pentamethylbenzyl)benzimidazolium chloride (2) have been optimized by DFT-based calculation methods.
💡
Conclusion & Impact:In addition, the interactions of optimized molecules with VEGFR-2 and TrxR crystal structures were analyzed by using molecular docking methods.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:N-Heterosiklik Karbenler · Anti-kanser · Moleküler Doking

Abstract

N-heterocyclic carbenes are a family of molecules that are frequently studied for their bioactivity. Since cancer is the second disease that causes death in the world, the anti-cancer properties of N heterocyclic carbenes is one of the analyzed activities. Considering the difficulties of studying the bioactivities of all candidate molecules, using in-silico methods for obtaining predictions is advantageous. With theoretical ways, both the properties of the existed molecules can be examined, and preliminary information can be obtained for designing of more suitable molecules. In this study, previously characterized of 1-(allyl)-3-(2,4,6-trimethylbenzyl)benzimidazolium chloride (1) and 1-(allyl)-3-(2,3,4,5,6-pentamethylbenzyl)benzimidazolium chloride (2) have been optimized by DFT-based calculation methods. In addition, the interactions of optimized molecules with VEGFR-2 and TrxR crystal structures were analyzed by using molecular docking methods.

Özet

N-heterosiklik karbenler biyoaktiviteleri dolayısıyla sıklıkla incelenen bir molekül ailesidir. Kanserin dünyada ölüme neden olan 2. hastalık olduğu için, N-heterosiklik karbenlerin anti-kanser aktivitesi de incelenen özellikler arasındadır. Bütün aday moleküllerin biyoaktivitesinin incelenmesinin zorlukları değerlendirildiğinde, in-siliko yöntemlerin öngörü elde etmek için kullanılması avantajlıdır. Teorik hesaplama yöntemleriyle, mevcut moleküllerin özellikleri incelenebildiği gibi daha uygun moleküllerin sentezlenmesi için önbilgiler elde edilebilir. Bu çalışmada daha önce karakterize edilmiş 1-(allil)-3-(2,4,6-trimetilbenzil)benzimidazolyum klorür (1) ve 1-(allil)-3-(2,3,4,5,6-pentametilbenzil)benzimidazolyum klorür (2) molekülleri DFT temelli hesap yöntemleri ile yapısal olarak incelenerek optimize edilmiştir. Optimize moleküllerin VEGFR-2 ve TrxR kristal yapıları ile etkileşimleri moleküler doking yöntemleri kullanılarak analiz edilmiştir.

🔖

Cite This Article

ÜSTÜN, E., ŞAHİN, N. (2021). Molecular Docking Analysis of Benzimidazolium Type Molecules with VEGFR-2 and TrxR Crystal Structures for Evaluating Anti-Cancer Activity. Ordu Üniversitesi Bilim ve Teknoloji Dergisi, Cilt: 11 - Sayı: 1, 36–44. https://ajindex.com/articles/262185

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Arduengo AJ, Harlow RL & Kline M. (1991) A stable crystalline carbene. Journal American Chemical Society 113(1):361–363. Arnér ESJ & Holmgren A. (2006) The thioredoxin system in cancer. Seminars in Cancer Biology 16(6):420-426. Dawson MA & Kouzarides T. (2012) Cancer Epigenetics: From Mechanism to Therapy. Cell 150(1):12-27. Frémont P, Marion N & Nolan SP. (2009) Cationic NHC–gold(I) complexes: Synthesis, isolation, and catalytic activity. Journal of Organometallic Chemistry 694(4):551-560.
  2. Ganther HE. (1999) Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20(9):1657–1666. Gupta GP & Massagué J. (2006) Cancer Metastasis: Building a Framework. Cell 127(4):679-695.
  3. Holt PA, Chaire JB & Trent JO. (2008) Molecular Docking of Intercalators and Groove-Binders to Nucleic Acids Using Autodock and Surflex. Journal of Chemical Information and Modeling 48(8):1602–1615. https://www.who.int/health-topics/cancer#tab=tab_1
  4. Kaya S, Banerjee P, Sah S,Tüzün B & Kaya C. (2016) Theoretical evaluation of some benzotriazole and phospono derivatives as aluminum corrosion inhibitors: DFT and molecular dynamics simulation approaches. RSC Advances 6:74550-74559.
  5. Lincoln DT, Emadi AEM, Tonissen KF & Clarke FM. (2003) The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Research 23(3B):2425-2433.
  6. Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL & Siegel RL. (2019) Cancer treatment and survivorship statistics. CA: A Cancer Journal for Clinicians 69(5):363-385.
  7. Miyazaki Y, Matsunaga S, Tang J, Maeda Y, Nakano M, Philippe R.J, Shibahara M, Liu W, Sato H, Wang L & Nolte RT. Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors. Bioorganic Medical Chemical Letter 15:2203-2207.
  8. Mnasri A, Al-Ayed A.S. Özdemir İ, Gürbüz N, Naceur, H. (2021). A new PEPPSI type N-heterocyclic carbene palladium (II) complexes and its efficiency as a catalyst for Mizoroki-Heck cross-coupling reactions in water: Synthesis, Characterization and their antimicrobial and Cytotoxic activities. Journal of Molecular Structure, 1234: 130204. Morell C, Grand A & Toro-Labbé A. (2005) New Dual Descriptor for Chemical Reactivity Journal Physical Chemistry A 109(1):205–212.
  9. Nair V, Bindu S & Sreekumar V. (2004) N‐Heterocyclic Carbenes: Reagents, Not Just Ligands!. Angewandte Chemie International Edition 43(39):5130 –5135. Neese F, Wennmohs F, Becker U